4/25
07:00 am
mnmd
MindMed to Present at Upcoming May Medical Conferences
Low
Report
MindMed to Present at Upcoming May Medical Conferences
4/25
05:49 am
mnmd
This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher [Yahoo! Finance]
Low
Report
This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher [Yahoo! Finance]
4/19
05:39 pm
mnmd
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' [Yahoo! Finance]
Low
Report
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' [Yahoo! Finance]
4/17
04:35 pm
mnmd
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Medium
Report
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
4/15
08:18 am
mnmd
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $20.00 price target on the stock.
Low
Report
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $20.00 price target on the stock.
4/4
12:51 pm
mnmd
Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data [Seeking Alpha]
Neutral
Report
Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data [Seeking Alpha]
4/2
07:00 am
mnmd
MindMed to Present at Upcoming April Medical Conferences
Medium
Report
MindMed to Present at Upcoming April Medical Conferences
4/1
05:00 pm
mnmd
MindMed Announces Voluntary Delisting from Cboe Canada
Medium
Report
MindMed Announces Voluntary Delisting from Cboe Canada
3/28
07:32 am
mnmd
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance' [Yahoo! Finance]
Low
Report
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance' [Yahoo! Finance]
3/28
07:23 am
mnmd
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance' [BNN Bloomberg (Canada)]
Low
Report
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance' [BNN Bloomberg (Canada)]
3/18
03:10 pm
mnmd
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
3/15
09:45 am
mnmd
Thinking about buying stock in Mind Medicine, Ocean Biomedical, Archer Aviation, Outlook Therapeutics, or Cardiff Oncology?
Medium
Report
Thinking about buying stock in Mind Medicine, Ocean Biomedical, Archer Aviation, Outlook Therapeutics, or Cardiff Oncology?
3/11
07:00 am
mnmd
MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference
High
Report
MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference
3/8
07:12 am
mnmd
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder [Yahoo! Finance]
Medium
Report
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder [Yahoo! Finance]
3/8
07:00 am
mnmd
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder
Medium
Report
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder
3/7
01:05 pm
mnmd
PBM and NWGL among mid-day movers [Seeking Alpha]
Low
Report
PBM and NWGL among mid-day movers [Seeking Alpha]
3/7
11:35 am
mnmd
Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation [Seeking Alpha]
Medium
Report
Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation [Seeking Alpha]
3/7
11:17 am
mnmd
More from CNN [CNN]
Medium
Report
More from CNN [CNN]
3/7
07:13 am
mnmd
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
High
Report
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
3/7
07:07 am
mnmd
More from CNN [CNN]
Low
Report
More from CNN [CNN]
3/7
06:00 am
mnmd
MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
High
Report
MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
3/1
02:44 pm
mnmd
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
3/1
09:00 am
mnmd
MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
Medium
Report
MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
2/29
12:33 pm
mnmd
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target raised by analysts at Royal Bank of Canada from $14.00 to $15.00. They now have an "outperform" rating on the stock.
Low
Report
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target raised by analysts at Royal Bank of Canada from $14.00 to $15.00. They now have an "outperform" rating on the stock.
2/28
07:05 am
mnmd
MindMed Reports 2023 Financial Results and Business Updates
Low
Report
MindMed Reports 2023 Financial Results and Business Updates